Giulia Piomboni

Giulia Piomboni

Auto-generated profile, based on publicly available information

Giulia Piomboni


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ICIlaria Chiarugi
Ilaria Chiarugi
Francesca MaestrelliFrancesca Maestrelli
Francesca Maestrelli
GPGiulia Piomboni
Giulia Piomboni
Sandra RistoriSandra Ristori
Sandra Ristori
ABAnna Rita Bilia
Anna Rita Bilia
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represent a therapeutic challenge, though very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical versatility make them powerful building blocks for the design of supramolecular nanovectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this context, CD-based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for siRNA delivery, discussing the role played by structural differences and chemical functionalization in the context of encapsulation and release.

24 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ICIlaria Chiarugi
Ilaria Chiarugi
Francesca MaestrelliFrancesca Maestrelli
Francesca Maestrelli
GPGiulia Piomboni
Giulia Piomboni
Sandra RistoriSandra Ristori
Sandra Ristori
ABAnna Rita Bilia
Anna Rita Bilia
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represents a therapeutic challenge and very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical ver-satility make them powerful building blocks for the design of supramolecular nano-vectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this contest CD based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery systems. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for delivery of siRNA, discussing the ins and outs of structural differences and chemical functionalization.